Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
SelectQuote
SLQT
$126M
| $11.4M | ﹤0.01% |
884,560
+390,350
| +79% | +$5.88M |
|
|
KAMN
1927
DELISTED
Kaman Corp
KAMN
| $11.4M | ﹤0.01% |
320,627
+17,632
| +6% | +$728K |
|
1928
US Physical Therapy
USPH
$1.24B
| $11.4M | ﹤0.01% |
103,042
+6,611
| +7% | +$753K |
|
1929
Axcelis
ACLS
$4.42B
| $11.4M | ﹤0.01% |
242,241
-10,108
| -4% | -$440K |
|
1930
Camping World
CWH
$675M
| $11.4M | ﹤0.01% |
292,811
-53,864
| -16% | -$2.12M |
|
1931
Quince Therapeutics
QNCX
$33M
| $11.4M | ﹤0.01% |
621
+92
| +17% | +$1.46M |
|
|
SAGE
1932
DELISTED
Sage Therapeutics
SAGE
| $11.3M | ﹤0.01% |
255,933
-17,422
| -6% | -$799K |
|
1933
Constellium
CSTM
$3.95B
| $11.3M | ﹤0.01% |
601,990
+12,758
| +2% | +$246K |
|
1934
AMERISAFE
AMSF
$504M
| $11.3M | ﹤0.01% |
200,790
+12,025
| +6% | +$686K |
|
1935
Grocery Outlet
GO
$1.07B
| $11.3M | ﹤0.01% |
522,419
+49,010
| +10% | +$1.41M |
|
|
UMH
1936
UMH Properties
UMH
$1.42B
| $11.3M | ﹤0.01% |
491,857
+17,899
| +4% | +$418K |
|
1937
World Acceptance Corp
WRLD
$875M
| $11.3M | ﹤0.01% |
59,386
-1,155
| -2% | -$213K |
|
|
SHCR
1938
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $11.3M | ﹤0.01% |
+1,367,635
| New | +$10.3M |
|
1939
Travere Therapeutics
TVTX
$5.79B
| $11.3M | ﹤0.01% |
463,879
-176,236
| -28% | -$3.24M |
|
1940
Liberty Energy
LBRT
$3.45B
| $11.2M | ﹤0.01% |
926,124
+104,325
| +13% | +$1.16M |
|
1941
Amdocs
DOX
$6.23B
| $11.2M | ﹤0.01% |
148,298
-13,688
| -8% | -$1.06M |
|
|
GCP
1942
DELISTED
GCP Applied Technologies Inc.
GCP
| $11.2M | ﹤0.01% |
511,621
+37,515
| +8% | +$870K |
|
|
VIVO
1943
DELISTED
Meridian Bioscience Inc
VIVO
| $11.2M | ﹤0.01% |
582,088
+690
| +0.1% | +$13.8K |
|
1944
Standard Motor Products
SMP
$870M
| $11.2M | ﹤0.01% |
255,845
+14,394
| +6% | +$617K |
|
|
EPAY
1945
DELISTED
Bottomline Technologies Inc
EPAY
| $11.2M | ﹤0.01% |
283,850
+2,159
| +0.8% | +$87K |
|
1946
National Bank Holdings
NBHC
$1.94B
| $11.1M | ﹤0.01% |
275,256
+1,413
| +0.5% | +$51.7K |
|
1947
LendingTree
TREE
$461M
| $11.1M | ﹤0.01% |
79,685
+2,186
| +3% | +$383K |
|
1948
ADT
ADT
$5.46B
| $11.1M | ﹤0.01% |
1,376,281
+194,716
| +16% | +$1.79M |
|
|
VCRA
1949
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $11.1M | ﹤0.01% |
243,077
-7,806
| -3% | -$348K |
|
1950
Coeur Mining
CDE
$19B
| $11.1M | ﹤0.01% |
1,792,031
-68,267
| -4% | -$485K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.